As shown in Figure 1, serum glypican-4 levels were higher in the GDM group compared to the NGT group throughout the whole pregnancy, with significant differences observed during 24-28 weeks of gestation and 29-40 weeks of gestation (P< 0.05). This evidence concerns the gene GPC4 and gestational diabetes.